POSTERS
Posters with an odd number are presented during Poster Session 1 (Sunday, 19 June). Posters with an even number are presented during Poster Session 2 (Monday, 20 June). The recommended poster size is 110 x 90 cm (height x width) for "Portrait" or 90 x 110 cm (height x width) for "Landscape"; please be aware that the maximum surface area available for your poster is 114 x 114 cm.
P.1 Amira Abd-Jamil (Oxford, United Kingdom)
Modification of PPARα activity is detrimental to cardiac function during chronic hypoxia – critical role of PPARα on cardiac substrate metabolism
|
P.2 E. Dale Abel (Salt Lake City, USA)
Insulin receptors deletion in the mouse heart prevents cardiac auging despite reduced autophagy
|
P.3 Yeliz Angin (Maastricht, Netherlands)
The Role of Ca 2+ Signaling in Contraction Stimulated Long-Chain Fatty Acid and Glucose Uptake into the Heart
|
P.4 Julien Auquier (Brussels, Belgium)
Inhibition of the mTOR/p70S6K pathway does not restore glucose uptake in insulin-resistant adult rat cardiomyocytes
|
P.5 Jean-Luc Balligand (Brussels, Belgium)
Paracrine NO potentiates the differentiation of adult cardiac resident stem cells in co-culture with cardiac myocytes |
P.6 Jean-Luc Balligand (Brussels, Belgium)
Statins prevent LV remodelling through anti-fibrotic effects rather than direct effects on cardiomyocytes in a mouse model of metabolic syndrome |
P.7 Magali Balteau (brussels, Belgium)
NADPH oxidase activation by hyperglycemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1
|
P.8 Rachel Brewer (Birmingham, USA)
Influence of the mitochondrial ATP-Pi transporter SLC25A25 on myocardial metabolism and contractile function
|
P.9 Thomas Joseph Butler (Hull, United Kingdom)
Western diet and the hypertrophied heart: the sugary path to failure?
|
P.10 Andrea Cordero-Reyes (Houston, USA)
Substrate preference in ischemic vs. non-ischemic cardiomyopathy in human heart mitochondria
|
P.11 Carole de Meester (Bruxelles, Belgium)
The proliferation state of mesenchymal stem cells is regulated by AMP-activated protein kinase
|
P.12 Bénédicte Demeulder (woluwe-st-Lambert, Belgium)
The AMP-activated protein kinase activator A-769662 prevents phenylephrine-induced cardiomyocyte hypertrophy by blocking multiple signaling elements
|
P.13 Stéphane Demine (Namur, Belgium)
Effect of a mild mitochondrial uncoupling on lipolysis and endocrine functions of adipocytes
|
P.14 Gaurang Deshpande (Cape Town, South Africa)
Sphingosine-1-phosphate (S-1-P) and glucose: dawn of new therapeutic approaches to acute heart failure (AHF)?
|
P.15 Monika Dornbierer (Berne, Switzerland)
Use of non-heartbeating donors in cardiac transplantation: Is functional recovery of hearts predictable? |
P.16 Ronald Driesen (Leuven, Belgium)
Cardiac myocyte remodeling in the adjacent and remote myocardium of a chronic myocardial infarction
|
P.17 Thomas Eykyn (London, United Kingdom)
Metabolic imaging in the isolated perfused rat heart using hyperpolarised [1-13C] pyruvate
|
P.18 Audrey Ginion (Brussels, Belgium)
Activation of the mTOR/p70S6K pathway by leucine does not reduce the insulin-stimulated glucose uptake in adult rat cardiomyocytes
|
P.19 Anisha Gupte (Houston, USA)
Left Ventricular Assist Devices induce gene expression for myocardial substrate oxidation in heart failure
|
P.20 Anne Dragøy Hafstad (Tromsø, Norway)
High intensity interval training normalizes cardiac energetics and ventricular function in diet-induced obese mice
|
P.21 Charles R. Haggart (Charlottesville, USA)
Genome-scale modeling of normal and heart failure-associated cardiac metabolism
|
P.22 Martin Hagve (Tromsø, Norway)
Palmitate-induced uncoupling reduces oxidative stress in cardiac mitochondria respiring on complex II substrate
|
P.23 Mark Holness (London, United Kingdom)
Early over -exposure to glucocorticoids permanently programmes the cardiac response to dietary lipid such that glucose transport capacity is uncoupled from glucose oxidation
|
P.24 Sander Houten (Amsterdam, Netherlands)
Carnitine supplementation in long-chain acyl-CoA dehydrogenase knock-out mice does not affect cardiac function
|
P.25 Barbara Huisamen (Tygerberg, South Africa)
A profile of the myocardial metabolic changes associated with a rat model of diet-induced obesity
|
P.26 Jamie Imbriolo (Stellenbosch, South Africa)
The hexosamine biosynthetic pathway induces gene promoter activity of the cardiac-enriched isoform of acetyl-CoA carboxylase
|
P.27 Thunder Jalili (Salt Lake City, USA)
Discordance between cardiac hypertrophy and oxidative stress in cardiac specific GLUT4 deleted mice treated with antioxidants
|
P.28 Danzil Joseph (Stellenbosch, South Africa)
Exploring novel therapeutic targets to blunt hexosamine biosynthetic pathway-induced myocardial insulin resistance
|
P.29 Arulmozhi Kandasamy (Edmonton, Canada)
Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice
|
P.30 Petra Kienesberger (Edmonton, Canada)
Impaired oxidative substrate metabolism, pathological hypertrophy and cardiac steatosis in mice with inducible cardiomyocyte-specific ATGL deficiency
|
P.31 Jaetaek Kim (Seoul, Korea, Republic Of)
Glucosamine stimulates mitochondrial biogenesis in neonatal rat cardiomyocytes
|
P.32 Alexandra Koenig (Freiburg, Germany)
Preserved myocardial mitochondrial function in mice lacking adiponectin action
|
P.33 Dominic Lachance (Montréal, Canada)
A new mouse model of type 2 diabetes T2D induced by a high fat/high fructose (HF/HF) diet and a single low dose of streptozotocin (STZ)
|
P.34 Edward Lau (Los Angeles, USA)
Selective 20S proteasome-mediated proteolysis of cardiac mitochondrial proteins
|
P.35 Benjamin Lauzier (Montreal, Canada)
Glutamine a key modulator of cardiac fatty acid utilization: role of the hexosamine biosynthetic pathway and CD36
|
P.36 Sarah Longnus (Berne, Switzerland)
Resistance to ischemia-reperfusion injury is increased two-fold with mild hypothermia during global ischemia
|
P.37 Mieke Louwe (Leiden, Netherlands)
High fat lard diet alters cardiac function in TLR2-/- mice
|
P.38 Joost Luiken (Maastricht, Netherlands)
Beneficial effects of VAMP3 overexpression on myocellular lipid metabolites and insulin-stimulated GLUT4 translocation in an in-vitro model of cardiac lipotoxicity
|
P.39 Onselaer Marie-Blanche (Woluwe-Saint-Lambert, Belgium)
Role of metabolic signalling in human platelet aggregation
|
P.40 Jeevan Nagendran (Edmonton, Canada)
Doxorubicin-induced systolic dysfunction is prevented in mice with cardiomyocyte-specific ATGL over-expression
|
P.41 Jeevan Nagendran (Edmonton, Canada)
Resveratrol prevents doxorubicin-induced cardiac dysfunction
|
P.42 Rianne Nederlof (Amsterdam, Netherlands)
Disruption of hexokinase II-mitochondrial binding affects cardiac oxygen consumption and lactate production in the beating heart
|
P.43 Gauthier-Thibaut Noppe (Brussels, Belgium)
A-769662 demonstrates anti-fibrotic properties: a new potential role for AMP-activated protein kinase
|
P.44 Aaron Olson (Seattle, USA)
Temporal evolution of substrate oxidation changes in c-Myc induced cardiac hypertrophy
|
P.45 Mohamed Omar (Edmonton, Canada)
Role of p38 mitogen-activated protein kinase (p38 MAPK) in adenosine-mediated inhibition of glycolysis and improved left-ventricular (LV) mechanical function
|
P.46 Jared Powers (Los Angeles, USA)
Mitochondrial oxidative phosphorylation proteomes and their involvement in metabolic disorders of various organisms
|
P.47 Thomas Pulinilkunnil (Edmonton, Canada)
Diabetes-induced cardiac dysfunction is attenuated in mice with cardiomyocyte-specific ATGL over-expression
|
P.48 Ravichandran Ramasamy (New York, USA)
All-trans Retinoic Acid Attenuates Ischemia/Reperfusion Injury in Mutant Knock-in-Mouse Expressing Enhanced Aldose Reductase
|
P.49 Susanne Rohrbach (Giessen, Germany)
Mitochondrial biogenesis and PGC-1alpha deacetylation by chronic treadmill exercise: differential response in cardiac and skeletal muscle |
P.50 Matthieu Ruiz (Châtenay malabry, France)
Role of resveratrol on endothelial dysfunction and mitochondrial biogenesis in a model of hypertension-induced heart failure
|
P.51 Michael Schwarzer (Jena, Germany)
Role of mitochondrial ROS-production in pressure overload induced heart failure in rats
|
P.52 Richard Southworth (London, United Kingdom)
Development of novel copper bis(thisemicarbazone) complexes for imaging cardiac hypoxia
|
P.53 Laura Steinbusch (Maastricht, Netherlands)
Inhibition of fatty acid uptake and stimulation of glucose uptake as targets to restore cardiac insulin resistance
|
P.54 Mary Sugden (London, United Kingdom)
Combating lipotoxicity by PPARα-LXR signaling in skeletal muscle
|
P.55 Haipeng Sun (Los Angeles, USA)
Branched chain amino acids catabolism in cardiac contractility and heart failure - implication of mitochondrial function |
P.56 David Taylor (Hull, United Kingdom)
Mitochondrial dysfunction in experimental uraemia
|
P.57 Diogo Teodoro Galan (Leuven, Belgium)
Mitochondrial adaptations in the adjacent and remote myocardium of a chronic myocardial infarction
|
P.58 Aurélie Timmermans (Bruxelles, Belgium)
Potentiation effect of the new AMPK activator A-769662 on glucose uptake induced by other AMPK activators in the heart
|
P.59 Fanny Vaillant (Montreal, Canada)
Metabolic and functional phenotyping of ex vivo atherosclerotic mouse working hearts. The difference is in the control strain!
|
P.60 An Van Berendoncks (Edegem, Belgium)
Effect of exercise training on functional adiponectin resistance and impaired skeletal muscle metabolism in patients with chronic heart failure
|
P.61 Olivier Van Caenegem (Bruxelles, Belgium)
Hypothermic machine perfusion improves metabolic preservation of heart grafts from non heart beating donors
|
P.62 Annelies Vanderper (Leuven, Belgium)
Failing delayed hypoxic preconditioning in mouse model of the metabolic syndrome: in search of underlying mechanisms
|
P.63 Sebastian Vogt (Marburg, Germany)
Induction of Heat Shock- Proteins results in increased enzyme activity of Cytochrome c Oxidase, but also in mRNA expression for COX 1 for better myocardial recovery
|
P.64 Ingrid Webster (Cape Town, South Africa)
Elucidating the role of MKP-1 in insulin-mediated cardioprotection of the rat heart
|
P.65 Ingrid Webster (Cape Town, South Africa)
The effect of creatine supplementation on myocardial metabolism and function in sedentary and exercised rats
|
P.66 Adam Wende (Salt Lake City, USA)
Pyruvate dehydrogenase kinase 2 deficiency attenuates contractile dysfunction in response to pressure overload-induced heart failure
|
P.67 Martin Young (Birmingham, USA)
MuRF1 regulates cardiac function and glucose/fatty acid oxidation in the working heart
|
P.68 Martin Young (Birmingham, USA)
Time-of-day-dependent regulation of glucose metabolism by the cardiomyocyte circadian clock
|
Important dates
-
Registrations and abstract submissions open
8 December 2010 -
Notification of abstract selections
15 April 2011
Deadlines
-
Abstract submissions
1 April 2011 -
Early bird registrations
1 April 2011
Organising Committee
E. Dale Abel (Co-Chair)
Salt Lake City, UT
Luc Bertrand (Co-Chair)
Brussels, Belgium
Christophe Beauloye (Co-Chair)
Brussels, Belgium
Sandrine Horman
Brussels, Belgium
Louis Hue
Brussels, Belgium
Jean-Louis Vanoverschelde
Brussels, Belgium
Christine Des Rosiers
Montreal, Québec
Jan Glatz
Maastricht, The Netherlands